Novo, GlaxoSmithKline and Merck-backed molecular profiling platform HTG offered almost 3.6 million shares priced at $14 each.

Pet medicine developer Jaguar Animal Health, backed by Napo Pharmaceuticals, raised $20m after receiving $2.2m of venture funding.

Twitter revealed in its earnings report that it spent a combined $86.6m to acquire William Morris Endeavor-backed Niche and Periscope earlier this year.

Novo Seeds, Lundbeck, Merck and Astellas all exited EpiTherapeutics after it was acquired by biopharmaceutical firm Gilead.

Galapagos has increased the target for its upcoming IPO on Nasdaq to $230m, while $55m of the stock could be bought by AbbVie and Johnson & Johnson.

Novo Seeds, Lundbeck, Merck and Astellas all exited EpiTherapeutics after it was acquired by biopharmaceutical firm Gilead.

The wearable fitness device maker has raised $83m in funding from investors including SoftBank and Qualcomm.

The energy utility divested its stake in EEW Energy from Waste to private equity firm EQT, which now wholly owns the waste-to-energy company.

The health services management company, founded by UPMC Health Plan and The Advisory Board Company, has targeted $100m for its initial public offering.

The cancer therapeutics developer, backed by Novo and Immunocore, raised the cash less than a year after closing a nine-figure series A round.